Technical challenges and quality considerations for dissolving microneedles.

Saved in:
Bibliographic Details
Title: Technical challenges and quality considerations for dissolving microneedles.
Authors: Kamal NS; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA. Electronic address: nahid.kamal@fda.hhs.gov., Acheampong S; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Zaman RU; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Strasinger C; Office of Pharmaceutical Quality Assessment II, OPQ, CDER, FDA, USA., Clark AG; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA., Zhu A; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA., Tang Y; Office of Pharmaceutical Quality Assessment III, OPQ, CDER, FDA, USA., Zidan A; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA., Ashraf M; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA.
Source: International journal of pharmaceutics [Int J Pharm] 2026 May 05; Vol. 696, pp. 126830. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41921709
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Technical challenges and quality considerations for dissolving microneedles.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kamal+NS%22">Kamal NS</searchLink>; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA. Electronic address: nahid.kamal@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Acheampong+S%22">Acheampong S</searchLink>; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA.<br /><searchLink fieldCode="AU" term="%22Zaman+RU%22">Zaman RU</searchLink>; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA.<br /><searchLink fieldCode="AU" term="%22Strasinger+C%22">Strasinger C</searchLink>; Office of Pharmaceutical Quality Assessment II, OPQ, CDER, FDA, USA.<br /><searchLink fieldCode="AU" term="%22Clark+AG%22">Clark AG</searchLink>; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+A%22">Zhu A</searchLink>; digiM Solution 500 West Cummings Park, Woburn, MA 01801, USA.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; Office of Pharmaceutical Quality Assessment III, OPQ, CDER, FDA, USA.<br /><searchLink fieldCode="AU" term="%22Zidan+A%22">Zidan A</searchLink>; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA.<br /><searchLink fieldCode="AU" term="%22Ashraf+M%22">Ashraf M</searchLink>; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality (OPQ), CDER, FDA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227804127%22">International journal of pharmaceutics</searchLink> [Int J Pharm] 2026 May 05; Vol. 696, pp. 126830. <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7804127 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3476 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203785173%22">03785173 </searchLink><i>NLM ISO Abbreviation: </i>Int J Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41921709
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijpharm.2026.126830
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 126830
    Titles:
      – TitleFull: Technical challenges and quality considerations for dissolving microneedles.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kamal NS
      – PersonEntity:
          Name:
            NameFull: Acheampong S
      – PersonEntity:
          Name:
            NameFull: Zaman RU
      – PersonEntity:
          Name:
            NameFull: Strasinger C
      – PersonEntity:
          Name:
            NameFull: Clark AG
      – PersonEntity:
          Name:
            NameFull: Zhu A
      – PersonEntity:
          Name:
            NameFull: Tang Y
      – PersonEntity:
          Name:
            NameFull: Zidan A
      – PersonEntity:
          Name:
            NameFull: Ashraf M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 05
              Text: 2026 May 05
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-3476
          Numbering:
            – Type: volume
              Value: 696
          Titles:
            – TitleFull: International journal of pharmaceutics
              Type: main
ResultId 1